Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Breast Biopsy Market Growth Potential: How Will Market Size Shift Through 2030?
The breast biopsy market has experienced substantial expansion in recent years. Projections indicate its value will rise from $1.53 billion in 2025 to $1.65 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. Factors contributing to its historical growth include the limited availability of advanced biopsy systems, a reliance on traditional surgical biopsy methods, a rising incidence of breast cancer, the expansion of hospital and diagnostic center infrastructure, and the increasing adoption of ultrasound-guided procedures.
The breast biopsy market size is projected to experience substantial growth in the upcoming years. It is expected to expand to reach $2.17 billion in 2030, driven by a compound annual growth rate (CAGR) of 7.2%. This growth over the forecast period can be attributed to several factors such as technological advancements in liquid biopsy and imaging-guided systems, a heightened awareness regarding early breast cancer detection, the expansion of diagnostic centers and hospitals, increasing integration of AI and data analytics, and the development of personalized and precision medicine approaches. Significant trends anticipated during this period include a rising adoption of minimally invasive biopsy procedures, increased utilization of liquid biopsy techniques, the proliferation of imaging-guided biopsy systems, an expansion of breast cancer diagnostic and screening programs, and an enhanced focus on patient safety and the accuracy of samples.
Get A Free Sample Report With In-Depth Market Insights:
Breast Biopsy Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing incidence of breast cancer is projected to drive the growth of the breast biopsy market in the future. This condition involves a malignant tumor forming in breast tissue cells, which can metastasize to other body parts if not treated without delay. The widespread presence of breast cancer is linked to factors such as longer life expectancies, advancements in detection methods, and greater public awareness of the disease. A breast biopsy serves to extract tissue samples from questionable areas in the breast to diagnose and identify the features of breast cancer. For example, in October 2025, Breastcancer.org, a US-based non-profit organization, reported that in 2025, an estimated 316,950 women are anticipated to be diagnosed with invasive breast cancer, along with about 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Thus, the expanding prevalence of breast cancer is propelling the development of the breast biopsy market.
Breast Biopsy Market Segmentation: How Does The Market Break Down By Category?
The breast biopsy market covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications
Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
#Breast Biopsy Market Growth Trends: What’s Shaping The Future Outlook?
Major companies within the breast biopsy marker market are concentrating on developing innovative products, such as ultrasound-visible site markers, to improve lesion localization and reduce marker displacement during breast biopsy procedures. An ultrasound-visible site marker is a specially designed implantable device that enhances the visualization of biopsy sites during imaging and provides stable localization for future surgical intervention. For instance, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, introduced HydroMark Plus. This new breast biopsy site marker offers improved lesion visibility on ultrasound, which assists radiologists and surgeons in accurately targeting biopsy sites while minimizing the risk of marker displacement during subsequent surgical procedures. As the latest addition to Mammotome’s HydroMark portfolio, HydroMark Plus is designed for enhanced procedural reliability and is slated for nationwide availability in the U.S. by the end of the year. The product’s key features include high ultrasound conspicuity for easy detection, minimized risk of movement within breast tissue, and suitability for a wide variety of breast imaging and interventional workflows. These attributes are aimed at improving clinical outcomes and procedural confidence for both physicians and patients.
Breast Biopsy Market Key Participants And Competitive Landscape
Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.
View The Full Breast Biopsy Market Report:
Breast Biopsy Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
